ECOPLADIBUM manufacturers
- Ecopladib
-
- $350.00
-
2026-07-14
- CAS:381683-92-7
- Purity: 99.02%
- Supply Ability: 10g
- Ecopladib
-
- $350.00
-
2026-07-14
- CAS:381683-92-7
- Purity: 99.02%
- Supply Ability: 10g
|
| | ECOPLADIBUM Basic information |
| Product Name: | ECOPLADIBUM | | Synonyms: | ECOPLADIBUM;4-(2-(5-chloro-2-(2-(((3,4-dichlorobenzyl)sulfonyl)aMino)ethyl)-1-(diphenylMethyl)-1H-indol-3-yl)ethoxy)benzoic acid;Ecopladib
(PLA 725);PLA 725;Benzoic acid, 4-[2-[5-chloro-2-[2-[[[(3,4-dichlorophenyl)methyl]sulfonyl]amino]ethyl]-1-(diphenylmethyl)-1H-indol-3-yl]ethoxy]-;Ecopladib, 10 mM in DMSO;Ecopladib | | CAS: | 381683-92-7 | | MF: | C39H33Cl3N2O5S | | MW: | 748.11 | | EINECS: | | | Product Categories: | | | Mol File: | 381683-92-7.mol |  |
| | ECOPLADIBUM Chemical Properties |
| Melting point | 124-125 °C | | Boiling point | 912.3±75.0 °C(Predicted) | | density | 1.35±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Solid | | pka | 4.46±0.10(Predicted) | | color | White to off-white |
| | ECOPLADIBUM Usage And Synthesis |
| Uses | Treatment of pain and symptomatic management of arthritis. | | in vivo | Ecopladib is orally efficacious in this model and displays an ED50 of 8 mg/kg, demonstrating that it can inhibit COX-2 derived PGE2 formation in vivo. Ecopladib is orally efficacious at reducing carrageenan-induced paw swelling:from doseresponse studies, it is determined that the ED50 is 40 mg/kg[1]. |
| | ECOPLADIBUM Preparation Products And Raw materials |
|